HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.

AuthorsHideaki Uchida, Masahiro Kamata, Aika Kato, Itsumi Mizukawa, Ayu Watanabe, Ai Agematsu, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 84 Issue 2 Pg. 547-550 (Feb 2021) ISSN: 1097-6787 [Electronic] United States
PMID32479977 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • dupilumab
Topics
  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized (administration & dosage, adverse effects)
  • Biomarkers (blood)
  • Dermatitis, Atopic (blood, diagnosis, drug therapy, immunology)
  • Female
  • Humans
  • Japan
  • Leukocyte Count
  • Male
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: